27 Recruiting Pancreatic Cancer Phase 1 Clinical Trials
Active phase 1 studies for pancreatic cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Pancreatic Cancer studiesPhase 1 Studies for Pancreatic Cancer
Intraoperative Radiation Therapy After Stereotactic Body Radiation Therapy and Chemotherapy in Treatment of Pancreatic Adenocarcinoma
📍 Johns Hopkins Hospital — Baltimore, Maryland
View Study & Checklist ➔First in Human Phase1/2a Clinical Trial of Anti-PAUF Monoclonal Antibody PBP1510 in Patients With Pancreatic Cancer
📍 Northwell Health / R.J. Zuckerberg Cancer Center — New Hyde Park, New York
View Study & Checklist ➔A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic Cancer
📍 Ambulatory Care Center — New York, New York
View Study & Checklist ➔huCART-meso + VCN-01 in Pancreatic and Ovarian Cancer
📍 University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔Study of Personalized Tumor Vaccines (PCVs) and a PD-L1 Blocker in Patients With Pancreatic Cancer That Can be Treated With Surgery
📍 Memorial Sloan Kettering Basking Ridge (All Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors
📍 NGM Clinical Study Site — Gilbert, Arizona
View Study & Checklist ➔A Study of Armed, Activated T-Cells in Patients With Advanced Pancreatic Cancer
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
📍 University of Arizona Cancer Center — Tucson, Arizona
View Study & Checklist ➔Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer
📍 University of Rochester — Rochester, New York
View Study & Checklist ➔Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma
📍 University of Colorado — Aurora, Colorado
View Study & Checklist ➔A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer
📍 Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II)
📍 Stanford University — San Francisco, California
View Study & Checklist ➔Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy (SBRT) in Participants With Cancer-Related Celiac Pain
📍 University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center — Cleveland, Ohio
View Study & Checklist ➔Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic Cancer
📍 Zuckerberg Cancer Center — New Hyde Park, New York
View Study & Checklist ➔ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer
📍 California Research Institute — Los Angeles, California
View Study & Checklist ➔Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer
📍 Johns Hopkins Sidney Kimmel Comprehensive Cancer Center — Baltimore, Maryland
View Study & Checklist ➔Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source
📍 Tampa General Hospital — Tampa, Florida
View Study & Checklist ➔Onvansertib in Combination With NALIRIFOX for First Line Treatment of Advanced Pancreatic Cancer
📍 The University of Kansas Cancer Center, Westwood Campus — Kansas City, Kansas
View Study & Checklist ➔PhIbRandomGemcitabine(G)w/or w/Out Pitavastatin(P)MainTx UnresecPancreaticAdenocarcinoma(uPDAC)
📍 Chao Family Comprehensive Cancer Center, University of California, Irvine — Orange, California
View Study & Checklist ➔EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)
📍 Tisch Hospital — New York, New York
View Study & Checklist ➔Lidocaine Infusion in Pancreatic Cancer
📍 University of Illnois at Chicago — Chicago, Illinois
View Study & Checklist ➔Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer
📍 UCSD Moores Cancer Center — La Jolla, California
View Study & Checklist ➔Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔